Suppr超能文献

老年人甲状腺激素起始治疗的预测因素:来自心血管健康研究的结果。

Predictors of thyroid hormone initiation in older adults: results from the cardiovascular health study.

机构信息

Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, USA.

出版信息

J Gerontol A Biol Sci Med Sci. 2011 Jul;66(7):809-14. doi: 10.1093/gerona/glr063. Epub 2011 May 31.

Abstract

BACKGROUND

Despite widespread use, there are no data on initiation of thyroid hormone use in older people. We report the prevalence of thyroid hormone use and predictors of thyroid hormone initiation in a population of older men and women.

METHODS

Thyroid hormone medication data were collected annually from 1989 to 2006 in community-dwelling individuals aged 65 years and older enrolled in the Cardiovascular Health Study (N = 5,888). Associations of age, sex, race, body mass index, education, and coronary heart disease with initiation were evaluated using discrete-time survival analysis.

RESULTS

In 1989-1990, 8.9% (95% confidence interval 8.1%-9.7%) of participants were taking a thyroid hormone preparation, increasing to 20.0% (95% confidence interval 8.2%-21.8%) over 16 years. The average initiation rate was 1% per year. The initiation rate was nonlinear with age, and those aged 85 years and older initiated thyroid hormone more than twice as frequently as those aged 65-69 years (hazard ratio = 2.34; 95% confidence interval 1.43-3.85). White women were more likely to initiate thyroid hormone than any other race and sex group. Higher body mass index was independently associated with higher risk for initiation (p = .002) as was greater education (p = .02) and prevalent coronary heart disease (p = .03).

CONCLUSIONS

Thyroid hormone use is common in older people. The indications and benefits of thyroid hormone use in older individuals with the highest rate of thyroid hormone initiation-the oldest old, overweight and obese individuals, and those with coronary heart disease-should be investigated.

摘要

背景

尽管甲状腺激素的应用已经广泛,但在老年人中关于其应用起始的相关数据仍然缺乏。本研究报告了在一个老年男性和女性人群中,甲状腺激素应用的流行情况及其起始应用的预测因素。

方法

从 1989 年至 2006 年,我们每年收集一次参加心血管健康研究(CVHS)的年龄在 65 岁及以上的社区居住者的甲状腺激素药物数据(N=5888)。应用离散时间生存分析评估年龄、性别、种族、体重指数、教育程度和冠心病与起始应用的相关性。

结果

在 1989-1990 年,8.9%(95%置信区间 8.1%-9.7%)的参与者正在服用甲状腺激素制剂,16 年内增加到 20.0%(95%置信区间 8.2%-21.8%)。起始应用的平均速率为每年 1%。起始应用率随年龄呈非线性变化,85 岁及以上的人群起始应用甲状腺激素的频率是 65-69 岁人群的两倍多(风险比=2.34;95%置信区间 1.43-3.85)。白种女性比任何其他种族和性别组更有可能起始应用甲状腺激素。较高的体重指数与较高的起始应用风险独立相关(p=0.002),受教育程度较高(p=0.02)和存在冠心病(p=0.03)也与较高的起始应用风险相关。

结论

甲状腺激素在老年人中应用广泛。对于起始应用甲状腺激素频率最高的人群(最老的老年人、超重和肥胖的个体以及患有冠心病的个体),应该调查其应用甲状腺激素的指征和获益。

相似文献

引用本文的文献

3
Evaluating health outcomes in the treatment of hypothyroidism.评估甲状腺功能减退症治疗中的健康结局。
Front Endocrinol (Lausanne). 2022 Oct 18;13:1026262. doi: 10.3389/fendo.2022.1026262. eCollection 2022.
4
Towards De-Implementation of low-value thyroid care in older adults.向老年人群中低价值甲状腺护理的去执行化迈进。
Curr Opin Endocrinol Diabetes Obes. 2022 Oct 1;29(5):483-491. doi: 10.1097/MED.0000000000000758. Epub 2022 Jul 22.
5
Disparities in Thyroid Care.甲状腺护理中的差异。
Endocrinol Metab Clin North Am. 2022 Jun;51(2):229-241. doi: 10.1016/j.ecl.2021.11.017. Epub 2022 May 4.
7
Optimal Thyroid Hormone Replacement.甲状腺激素替代的最佳选择。
Endocr Rev. 2022 Mar 9;43(2):366-404. doi: 10.1210/endrev/bnab031.
8
The ages and TSH values of patients being prescribed levothyroxine.正在接受左甲状腺素治疗的患者的年龄和促甲状腺激素值。
Ther Adv Endocrinol Metab. 2020 Jul 2;11:2042018820937896. doi: 10.1177/2042018820937896. eCollection 2020.
9
Levothyroxine prescriptions trends may indicate a downtrend in prescribing.左甲状腺素的处方趋势可能表明处方量呈下降趋势。
Ther Adv Endocrinol Metab. 2020 May 19;11:2042018820920551. doi: 10.1177/2042018820920551. eCollection 2020.

本文引用的文献

3
Thyrotropin serum values and 3-year mortality in nonagenarians.百岁老人的促甲状腺激素血清值与3年死亡率
J Gerontol A Biol Sci Med Sci. 2010 Nov;65(11):1250-1; author reply 1252-3. doi: 10.1093/gerona/glq076. Epub 2010 May 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验